OneSource Specialty Pharma Limited (BOM:544292)

India · Delayed Price · Currency is INR

1,613.15

+5.75 (0.36%)

At close: Jun 22, 2026

-26.50% (1Y)

Market Cap	184.42B -16.2%
Revenue (ttm)	14.22B -1.6%
Net Income	-738.03M
EPS	-6.44
Shares Out	n/a
PE Ratio	n/a
Forward PE	41.31
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,094
Open	1,630.00
Previous Close	1,607.40
Day's Range	1,606.40 - 1,634.50
52-Week Range	1,075.00 - 2,211.70
Beta	n/a
Analysts	Buy
Price Target	2,036.75 (+26.26%)
Earnings Date	Jul 24, 2026

About BOM:544292

OneSource Specialty Pharma Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biological drug products in various injectable formats in India, Ireland, the United States, and internationally. The company provides end-to-end contract development and manufacturing operations (CDMO) services across various phases of preclinical and clinical development and commercial supply of biologics. It also offers drug-devices, including prefilled syringes, dial and push variable and fixed dose pe... [Read more]

Industry Commercial Physical and Biological Research

Founded 2007

Employees 1,412

Stock Exchange Bombay Stock Exchange

Ticker Symbol 544292

Full Company Profile

Financial Performance

In fiscal year 2026, BOM:544292's revenue was 14.22 billion, a decrease of -1.61% compared to the previous year's 14.45 billion. Losses were -738.03 million, 310.7% more than in 2025.

Financial Statements

Analyst Summary

According to 4 analysts, the average rating for 544292 stock is "Buy." The 12-month stock price target is ₹2,037, which is an increase of 26.26% from the latest price.

Price Target

₹2,037

(26.26% upside)

Analyst Consensus: Buy

Stock Forecasts